Historical review of clinical vaccine studies at Oswaldo Cruz Institute and Oswaldo Cruz Foundation--technological development issues

Memórias do Instituto Oswaldo Cruz
Reinaldo de Menezes MartinsAkira Homma

Abstract

This paper presents, from the perspective of technological development and production, the results of an investigation examining 61 clinical studies with vaccines conducted in Brazil between 1938-2013, with the participation of the Oswaldo Cruz Institute (IOC) and the Oswaldo Cruz Foundation (Fiocruz). These studies have been identified and reviewed according to criteria, such as the kind of vaccine (viral, bacterial, parasitic), their rationale, design and methodological strategies. The results indicate that IOC and Fiocruz have accumulated along this time significant knowledge and experience for the performance of studies in all clinical phases and are prepared for the development of new vaccines products and processes. We recommend national policy strategies to overcome existing regulatory and financing constraints.

References

Apr 1, 1988·Journal of Biological Standardization·S Lopes OdeR de Carvalho
Aug 1, 1995·The American Journal of Tropical Medicine and Hygiene·S C MendoncaV P Toledo
Sep 1, 1996·Revista Da Sociedade Brasileira De Medicina Tropical·M UrdanetaM Boulos
Apr 18, 1998·The American Journal of Tropical Medicine and Hygiene·M UrdanetaM Boulos
Sep 6, 2000·Revista de saúde pública·L A CamachoG Mann
Feb 23, 2002·Vaccine·Márcia Soares Freitas da MottaCleonice Barbosa Sandoval de Souza
Oct 23, 2004·Revista de saúde pública·Luiz Antonio Bastos CamachoUNKNOWN Collaborative Group for the Study of Yellow Fever Vaccines
Mar 12, 2005·Memórias do Instituto Oswaldo Cruz·Reinaldo Menezes MartinsLuiz Antonio Bastos Camacho
Jul 6, 2005·Revista de saúde pública·Luiz Antonio Bastos CamachoUNKNOWN Collaborative Group for the Study of Yellow Fever Vaccines
Aug 23, 2005·Memórias do Instituto Oswaldo Cruz·Ana Paula dos SantosRugimar Marcovistz
Feb 13, 2007·Memórias do Instituto Oswaldo Cruz·Ana Paula dos SantosRugimar Marcovistz
Apr 7, 2009·Cadernos de saúde pública·Ana Rita C Motta-CastroRegina M B Martins
Aug 4, 2009·Vaccine·Patrícia Cristina da Costa NevesRicardo Galler
Nov 7, 2009·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·D C S MatosR Marcovistz
Feb 4, 2011·The New England Journal of Medicine·Anna R GiulianoDalya Guris
Jun 7, 2011·Vaccine·Juliana Romualdo Nascimento SilvaUNKNOWN Collaborative Group for the Study of Yellow Fever Vaccines
Oct 7, 2011·The American Journal of Tropical Medicine and Hygiene·Andréa Barbosa de MeloMarli Tenório Cordeiro
Oct 28, 2011·The New England Journal of Medicine·Joel M PalefskyElizabeth I O Garner
Dec 14, 2011·Clinical and Vaccine Immunology : CVI·Richard J HillmanElizabeth I O Garner
May 29, 2012·The Journal of Allergy and Clinical Immunology·David J DiemertJeffrey M Bethony
Apr 23, 2013·Nanomedicine : Nanotechnology, Biology, and Medicine·Diego M SantosCamila I de Oliveira

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Bulletin of the Pan American Health Organization
J Leonard
Médecine tropicale : revue du Corps de santé colonial
C T Daniel Ribeiro, José Rodrigues Coura
Revista brasileira de malariologia e doenças tropicais. Publicações avulsas
C A de Freitas
© 2022 Meta ULC. All rights reserved